Search Results - "Bass, A.J."

Characterizing diversity in the tumor-immune microenvironment of distinct subclasses of gastroesophageal adenocarcinomas by Derks, S., de Klerk, L.K., Xu, X., Fleitas, T., Liu, K.X., Liu, Y., Dietlein, F., Margolis, C., Chiaravalli, A.M., Da Silva, A.C., Ogino, S., Akarca, F.G., Freeman, G.J., Rodig, S.J., Hornick, J.L., van Allen, E., Li, B., Liu, S.X., Thorsson, V., Bass, A.J.

“…Gastroesophageal adenocarcinomas (GEAs) are heterogeneous cancers where immune checkpoint inhibitors have robust efficacy in heavily inflamed microsatellite…”
Get full text

Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients by Kim, S.T., Banks, K.C., Pectasides, E., Kim, S.Y., Kim, K., Lanman, R.B., Talasaz, A., An, J., Choi, M.G., Lee, J.H., Sohn, T.S., Bae, J.M., Kim, S., Park, S.H., Park, J.O., Park, Y.S., Lim, H.Y., Kim, N.K.D., Park, W., Lee, H., Bass, A.J., Kim, K., Kang, W.K., Lee, J.

“…To identify predictive markers for responders in lapatinib-treated patients and to demonstrate molecular changes during lapatinib treatment via cell-free…”
Get full text

Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma by Goedegebuure, R.S.A., Harrasser, M., de Klerk, L.K., van Schooten, T.S., van Grieken, N.C.T., Eken, M., Grifhorst, M.S., Pocorni, N., Jordanova, E.S., van Berge Henegouwen, M.I., Pouw, R.E., Verheul, H.M.W., van der Vliet, J.J., van Laarhoven, H.W.M., Thijssen, V.L.J.L, Bass, A.J., De Gruijl, T.D., Derks, S.

“…Esophageal adenocarcinoma (EAC) is a disease with dismal treatment outcomes. Response to neoadjuvant chemoradiation (CRT) varies greatly. Although the…”
Get full text

Targeting the complexity of ERBB2 biology in gastroesophageal carcinoma by Augustin, J.E., Soussan, P., Bass, A.J.

“…ERBB2 is the most prominent therapeutic target in gastroesophageal adenocarcinoma (GEA). For two decades, trastuzumab was the only treatment available for GEA…”
Get full text

Corrigendum to “Targeting the complexity of ERBB2 biology in gastroesophageal carcinoma”: [Annals of Oncology 33 (2022) 1134-1148] by Augustin, J.E., Soussan, P., Bass, A.J.

Get full text

Cellular senescence checkpoint function determines differential Notch1-dependent oncogenic and tumor-suppressor activities by Kagawa, S, Natsuizaka, M, Whelan, K A, Facompre, N, Naganuma, S, Ohashi, S, Kinugasa, H, Egloff, A M, Basu, D, Gimotty, P A, Klein-Szanto, A J, Bass, A J, Wong, K-K, Diehl, J A, Rustgi, A K, Nakagawa, H

“…Notch activity regulates tumor biology in a context-dependent and complex manner. Notch may act as an oncogene or a tumor-suppressor gene even within the same…”
Get full text

An integrative analysis reveals functional targets of GATA6 transcriptional regulation in gastric cancer by Sulahian, R, Casey, F, Shen, J, Qian, Z R, Shin, H, Ogino, S, Weir, B A, Vazquez, F, Liu, X S, Hahn, W C, Bass, A J, Chan, V, Shivdasani, R A

“…Lineage-restricted transcription factors (TFs) are frequently mutated or overexpressed in cancer and contribute toward malignant behaviors; however, the…”
Get full text

Research use of linked health data--a best practice protocol by Kelman, C W, Bass, A J, Holman, C D J

“…This article outlines a protocol for facilitating access to administrative data for the purpose of health services research, when these data are sourced from…”
Get more information

Population‐based outcomes after 28 246 in‐hospital vasectomies and 1902 vasovasostomies in Western Australia by Holman, C.D.J., Wisniewski, Z.S., Semmens, J.B., Rouse, I.L., Bass, A.J.

“…Objectives To examine trends in vasectomy and vasovasostomy, and the surgical complications and factors associated with reversal after vasectomy, and paternity…”
Get full text

1121-61 Characterization of neointimal hyperplasia after sirolimus-eluting stent implantation in patients with previous brachytherapy failure: Insights from the SECURE study by Costa, Marco, Talwar, Kuldeep, Panse, Neeta, Teirstein, Paul, Carter Theodore, Yakubov S, Bass, A.J, Gilmore, Paul

Get full text

Reply by Holman, C.D.J., Wisniewski, Z.S., Semmens, J.B., Rouse, I.L., Bass, A.J.

Get full text

Reply by Holman, C.D.J., Wisniewski, Z.S., Semmens, J.B., Rouse, I.L., Bass, A.J.

Get full text

Changing treatments for primary urolithiasis: impact on services and renal preservation in 16 679 patients in Western Australia by Holman, C.D.J., Wisniewski, Z.S., Semmens, J.B., Bass, A.J.

“…Objectives  To examine changing treatments for the primary presentation of urinary lithiasis and their effects on re‐admissions, repeat procedures, cumulative…”
Get full text